(Q33830800)

29 July 2017

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406. (English)

1 reference

29 July 2017

0 references

0 references

1 reference

Michalski JM

1

1 reference

29 July 2017

Purdy JA

2

1 reference

29 July 2017

Winter K

3

1 reference

29 July 2017

Roach M 3rd

4

1 reference

29 July 2017

Vijayakumar S

5

1 reference

29 July 2017

Sandler HM

6

1 reference

29 July 2017

Markoe AM

7

1 reference

29 July 2017

Ritter MA

8

1 reference

29 July 2017

Russell KJ

9

1 reference

29 July 2017

Sailer S

10

1 reference

29 July 2017

Harms WB

11

1 reference

29 July 2017

Perez CA

12

1 reference

29 July 2017

Wilder RB

13

1 reference

29 July 2017

Hanks GE

14

1 reference

29 July 2017

Cox JD

15

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

International Journal of Radiation Oncology Biology Physics

29 July 2017

1 reference

29 July 2017

46

1 reference

29 July 2017

391-402

1 reference

29 July 2017

2

1 reference

The effect of dose on local control of prostate cancer.

29 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Tumor control in definitive irradiation of localized carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose-escalation study.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Late GI and GU complications in the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Conventional vs. conformal radiotherapy for prostate cancer: preliminary results of dosimetry and acute toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Phase III trial of androgen suppression using goserelin in unfavorable-prognosis carcinoma of the prostate treated with definitive radiotherapy: report of Radiation Therapy Oncology Group Protocol 85-31

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

The role of the urethrogram during simulation for localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Correlation of radiotherapeutic parameters and treatment related morbidity--analysis of RTOG Study 77-06

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Boost treatment of the prostate using shaped, fixed fields

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Chronic rectal bleeding after high-dose conformal treatment of prostate cancer warrants modification of existing morbidity scales.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Factors influencing incidence of acute grade 2 morbidity in conformal and standard radiation treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Locally advanced prostatic cancer: long-term toxicity outcome after three-dimensional conformal radiation therapy--a dose-escalation study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Late effects after radiotherapy for prostate cancer in a randomized dose-response study: results of a self-assessment questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: Further evidence for a significant dose effect

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

Dose escalation with 3D conformal treatment: five year outcomes, treatment optimization, and future directions.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900443-5

7 January 2021

10.1016/S0360-3016(99)00443-5

Identifiers

DOI

1 reference

29 July 2017

1 reference